Primary ADT not Associated with Improved OS for Localized PCa

Primary ADT is not Associated with Improved Long-term Overall or Disease-specific Survival for Men with Localized Prostate Cancer - Perspectives from the Editor-in-Chief (July 2014)

Thomas E. Keane, MD

Related Content:

Click HERE to read the abstract for Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer

Click HERE to listen to an interview with Siu-Long Yao, MD, one of the authors of the article Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer 

Click HERE to view the poster for Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer